Obesity, inflammation, and immune system in osteoarthritis

U Nedunchezhiyan, I Varughese, ARJ Sun… - Frontiers in …, 2022 - frontiersin.org
Obesity remains the most important risk factor for the incidence and progression of
osteoarthritis (OA). The leading cause of OA was believed to be overloading the joints due to …

Intra-articular treatment options for knee osteoarthritis

IA Jones, R Togashi, ML Wilson, N Heckmann… - Nature Reviews …, 2019 - nature.com
Intra-articular drug delivery has a number of advantages over systemic administration;
however, for the past 20 years, intra-articular treatment options for the management of knee …

[HTML][HTML] Intra-articular nanoparticles based therapies for osteoarthritis and rheumatoid arthritis management

J Wen, H Li, H Dai, S Hua, X Long, H Li, S Ivanovski… - Materials Today Bio, 2023 - Elsevier
Osteoarthritis (OA) and rheumatoid arthritis (RA) are chronic and progressive inflammatory
joint diseases that affect a large population worldwide. Intra-articular administration of …

Mechanisms of osteoarthritic pain. Studies in humans and experimental models

A Eitner, GO Hofmann, HG Schaible - Frontiers in molecular …, 2017 - frontiersin.org
Pain due to osteoarthritis (OA) is one of the most frequent causes of chronic pain. However,
the mechanisms of OA pain are poorly understood. This review addresses the mechanisms …

New trends in pharmacological treatments for osteoarthritis

X Cai, S Yuan, Y Zeng, C Wang, N Yu… - Frontiers in …, 2021 - frontiersin.org
Osteoarthritis (OA) is the leading cause of function loss and disability among the elderly, with
significant burden on the individual and society. It is a severe disease for its high disability …

Contribution of infrapatellar fat pad and synovial membrane to knee osteoarthritis pain

E Belluzzi, E Stocco, A Pozzuoli… - BioMed research …, 2019 - Wiley Online Library
Osteoarthritis (OA) is the most common form of joint disease and a major cause of pain and
disability in the adult population. Interestingly, there are patients with symptomatic OA …

Recent advances in intra-articular drug delivery systems for osteoarthritis therapy

P Maudens, O Jordan, E Allémann - Drug discovery today, 2018 - Elsevier
Highlights•Precision medicine is necessary to treat multiple facets of osteoarthritis.•Disease-
modifying osteoarthritis drugs (DMOADs) and drug delivery systems (DDSs) are …

[HTML][HTML] Osteoarthritis year in review 2016: clinical

NE Lane, K Shidara, BL Wise - Osteoarthritis and cartilage, 2017 - Elsevier
Both epidemiologic and clinical research continues to be performed in osteoarthritis (OA).
While epidemiologic studies identify risk factors for incident and progressive disease, clinical …

From pathogenesis to therapy in knee osteoarthritis: bench-to-bedside

E Rezuş, A Burlui, A Cardoneanu, LA Macovei… - International Journal of …, 2021 - mdpi.com
Osteoarthritis (OA) is currently the most widespread musculoskeletal condition and primarily
affects weight-bearing joints such as the knees and hips. Importantly, knee OA remains a …

Development and prospect of intra-articular injection in the treatment of osteoarthritis: a review

Y Zhang, X Chen, Y Tong, J Luo, Q Bi - Journal of Pain Research, 2020 - Taylor & Francis
Osteoarthritis (OA) is a common degenerative disease that affects the vast majority of the
elderly and may eventually embark on the road of the total knee arthroplasty (TKA), although …